| Ident. | Authors (with country if any) | Title |
|---|
| 000019 (2020) |
X Y Li [République populaire de Chine] ; B. Du [République populaire de Chine] ; Y S Wang [République populaire de Chine] ; H Y J. Kang [République populaire de Chine] ; F. Wang [République populaire de Chine] ; B. Sun [République populaire de Chine] ; H B Qiu [République populaire de Chine] ; Z H Tong [République populaire de Chine] | [The keypoints in treatment of the critical coronavirus disease 2019 patient]. |
| 000048 (2020) |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000058 (2020) |
K. Ma [République populaire de Chine] ; T. Chen ; M F Han ; W. Guo ; Q. Ning | [Management and clinical thinking of Coronavirus Disease 2019]. |
| 000074 (2020) |
| [Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)]. |
| 000136 (2020) |
J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine] | [Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures]. |
| 000139 (2020) |
H Y Tian [République populaire de Chine] | [2019-nCoV: new challenges from coronavirus]. |
| 000173 (2020) |
Oriol Mitjà [Espagne] ; Bonaventura Clotet [Espagne] | Use of antiviral drugs to reduce COVID-19 transmission. |
| 000204 (2020) |
Yaqing Fang [République populaire de Chine] ; Yiting Nie [République populaire de Chine] ; Marshare Penny [États-Unis] | Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis. |
| 000217 (2020) |
David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000239 (2020) |
Yi-Chi Wu [République populaire de Chine] ; Ching-Sung Chen [République populaire de Chine] ; Yu-Jiun Chan [République populaire de Chine] | The outbreak of COVID-19: An overview. |
| 000240 (2020) |
Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan Yan | The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status |
| 000264 (2020) |
Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine] | The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. |
| 000399 (2020) |
Hua-Hao Fan [République populaire de Chine] ; Li-Qin Wang ; Wen-Li Liu ; Xiao-Ping An ; Zhen-Dong Liu ; Xiao-Qi He ; Li-Hua Song ; Yi-Gang Tong | Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model. |
| 000469 (2020) |
Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong] | Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |
| 000559 (2020) |
Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis] | Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 |
| 000598 (2020) |
Tarun Bhatnagar [Inde] ; Manoj V. Murhekar [Inde] ; Manish Soneja [Inde] ; Nivedita Gupta [Inde] ; Sidhartha Giri [Inde] ; Naveet Wig [Inde] ; Raman Gangakhedkar [Inde] | Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use. |
| 000665 (2020) |
Md. Golzar Hossain [Bangladesh] ; Sharmin Akter ; Eriko Ohsaki ; Keiji Ueda | Impact of the Interaction of Hepatitis B Virus with Mitochondria and Associated Proteins |
| 000706 (2020) |
Shweta Saraswat ; Meenakshi Chaudhary ; Deepak Sehgal | Hepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by in silico Modeling and Cell-Free Inhibition Assays |
| 000726 (2020) |
Sara Cleemput [Belgique] ; Wim Dumon [Belgique] ; Vagner Fonseca [Afrique du Sud] ; Wasim Abdool Karim [Afrique du Sud] ; Marta Giovanetti [Brésil] ; Luiz Carlos Alcantara [Brésil] ; Koen Deforche [Belgique] ; Tulio De Oliveira [Afrique du Sud] | Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes. |
| 000825 (2020) |
Hongzhou Lu [République populaire de Chine] | Drug treatment options for the 2019-new coronavirus (2019-nCoV). |
| 000826 (2020) |
Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash Medhi | Drug targets for corona virus: A systematic review |
| 000828 (2020) |
Shibo Jiang | Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. |
| 000834 (2020) |
Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine] | Discovering drugs to treat coronavirus disease 2019 (COVID-19). |
| 000916 (2020) |
Michael Day | Covid-19: European drugs agency to review safety of ibuprofen. |
| 000A22 (2020) |
Yingxia Liu [République populaire de Chine] ; Yang Yang [République populaire de Chine] ; Cong Zhang [République populaire de Chine] ; Fengming Huang [République populaire de Chine] ; Fuxiang Wang [République populaire de Chine] ; Jing Yuan [République populaire de Chine] ; Zhaoqin Wang [République populaire de Chine] ; Jinxiu Li [République populaire de Chine] ; Jianming Li [République populaire de Chine] ; Cheng Feng [République populaire de Chine] ; Zheng Zhang [République populaire de Chine] ; Lifei Wang [République populaire de Chine] ; Ling Peng [République populaire de Chine] ; Li Chen [République populaire de Chine] ; Yuhao Qin [République populaire de Chine] ; Dandan Zhao [République populaire de Chine] ; Shuguang Tan [République populaire de Chine] ; Lu Yin [République populaire de Chine] ; Jun Xu [République populaire de Chine] ; Congzhao Zhou [République populaire de Chine] ; Chengyu Jiang [République populaire de Chine] ; Lei Liu [République populaire de Chine] | Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury |
| 000A46 (2020) |
Sheng-Qun Deng ; Hong-Juan Peng | Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China |
| 000A67 (2020) |
Murray Esler ; Danielle Esler [Australie] | Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| 000B03 (2020) |
Dan Zhou [République populaire de Chine] ; Sheng-Ming Dai [République populaire de Chine] ; Qiang Tong [République populaire de Chine] | COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. |
| 000B26 (2020) |
Piercarlo Sarzi-Puttini [Italie] ; Valeria Giorgi [Italie] ; Silvia Sirotti [Italie] ; Daniela Marotto [Italie] ; Sandro Ardizzone [Italie] ; Giuliano Rizzardini [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| 000B27 (2020) |
Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande] | COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. |
| 000B50 (2020) |
Ennio Giulio Favalli [Italie] ; Francesca Ingegnoli [Italie] ; Orazio De Lucia [Italie] ; Gilberto Cincinelli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie] | COVID-19 infection and rheumatoid arthritis: Faraway, so close! |
| 000B95 (2020) |
Jianjun Gao [République populaire de Chine] ; Zhenxue Tian [République populaire de Chine] ; Xu Yang [République populaire de Chine] | Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. |
| 000C25 (2020) |
Abdo A. Elfiky | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |
| 000D24 (2019) |
Ya Zhao [République populaire de Chine] ; Limin Feng [République populaire de Chine] ; Lijuan Liu [République populaire de Chine] ; Ruizhi Zhao [République populaire de Chine] | Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters |
| 000D38 (2019) |
Ajay Srivastava ; Rajiv Lall ; Jamil Talukder ; Dan Dubourdieu ; Ramesh C. Gupta [États-Unis] | Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases |
| 000D40 (2019) |
Lan Li ; Xiaoming Yu ; Haoming Zhang ; Haiwei Cheng ; Liting Hou ; Qisheng Zheng ; Jibo Hou | In vitro antiviral activity of Griffithsin against porcine epidemic diarrhea virus |
| 000E25 (2018) |
Marietta Nygaard [Danemark] ; Niels Smedegaard Andersen [Danemark] ; Claus Ernst Moser [Danemark] ; Gitte Olesen [Danemark] ; Ida Marie Schj Dt [Danemark] ; Carsten Heilmann [Danemark] ; Henrik Sengel V [Danemark] | Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival |
| 000F07 (2017) |
Aki Tanaka [Japon] ; Philip H. Kass ; Beatriz Martinez Lopez ; Shinichi Hayama [Japon] | Epidemiological evaluation of cat health at a first-response animal shelter in Fukushima, following the Great East Japan Earthquakes of 2011 |
| 000F75 (2016) |
Loïc Leclercq [France] | Interactions between cyclodextrins and cellular components: Towards greener medical applications? |
| 000F87 (2016) |
Takeo Kubota [Japon] ; Kazuki Mochizuki | Epigenetic Effect of Environmental Factors on Autism Spectrum Disorders |
| 000F88 (2016) |
Sushanto Gouda [Inde] ; Gitishree Das [Corée du Sud] ; Sandeep K. Sen [Inde] ; Han-Seung Shin [Corée du Sud] ; Jayanta Kumar Patra [Corée du Sud] | Endophytes: A Treasure House of Bioactive Compounds of Medicinal Importance |
| 001003 (2016) |
Alireza Tavasoli [Iran] ; Behdad Gharib [Iran] ; Houman Alizadeh [Iran] ; Hossein Farshadmoghaddam [Iran] ; Sara Memarian [Iran] ; Mahmoodreza Ashrafi [Iran] ; Meisam Sharifzade [Iran] | Brain on FIRES: Super Refractory Seizure in a 7 yr Old Boy |
| 001019 (2016) |
Abdo A. Elfiky [Égypte, Italie] | Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials |
| 001133 (2014) |
Veit Rothhammer [Allemagne] ; Andreas Muschaweckh [Allemagne] ; Georg Gasteiger [États-Unis] ; Franziska Petermann [Allemagne] ; Sylvia Heink [Allemagne] ; Dirk H. Busch [Allemagne] ; Mathias Heikenw Lder [Allemagne] ; Bernhard Hemmer [Allemagne] ; Ingo Drexler [Allemagne] ; Thomas Korn [Allemagne] | α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets |
| 001167 (2014) |
Tony Velkov [Australie] ; Nusaibah Abdul Rahim [Australie] ; Qi Tony Zhou [Australie] ; Hak-Kim Chan [Australie] ; Jian Li [Australie] | Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead |
| 001183 (2014) |
Mahendra Rai ; Kateryna Kon [Ukraine] ; Avinash Ingle ; Nelson Duran ; Stefania Galdiero [Italie] ; Massimiliano Galdiero [Italie] | Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects |
| 001187 (2014) |
Adeyemi O. Adedeji [États-Unis] ; Stefan G. Sarafianos [États-Unis] | Antiviral Drugs Specific for Coronaviruses in Preclinical Development |
| 001259 (2013) |
Andy Kilianski ; Susan C. Baker | Cell-based antiviral screening against coronaviruses: Developing virus-specific and broad-spectrum inhibitors |
| 001279 (2013) |
Holger Stephan [Allemagne] ; Manja Kubeil ; Franziska Emmerling [Allemagne] ; Christa E. Müller [Allemagne] | Polyoxometalates as Versatile Enzyme Inhibitors |
| 001283 (2013) |
Maja Schupfner [Allemagne] ; Gisela Greif [Allemagne] ; Matthias Lendner [Allemagne] ; Arwid Daugschies [Allemagne] ; Christoph Lippuner [Suisse] ; Georg Von Samson-Himmelstjerna [Allemagne] ; Jürgen Krücken [Allemagne] | Evaluation of Putative Anti-cryptosporidial Drugs in an in vitro Culture System |
| 001294 (2012) |
Eun Lee [Corée du Sud] ; Ju-Hee Seo [Corée du Sud] ; Hyoung-Young Kim [Corée du Sud] ; Jinho Yu [Corée du Sud] ; Jin Woo Song [Corée du Sud] ; Young Soo Park [Corée du Sud] ; Se-Jin Jang [Corée du Sud] ; Kyung-Hyun Do [Corée du Sud] ; Jiwon Kwon [Corée du Sud] ; Sung-Woo Park [Corée du Sud] ; Jeong-Hwan Park [Corée du Sud] ; Soo-Jong Hong [Corée du Sud] | Two Series of Familial Cases With Unclassified Interstitial Pneumonia With Fibrosis |
